276 related articles for article (PubMed ID: 33193629)
21. ANTXR1 as a potential prognostic biomarker for hepatitis B virus-related hepatocellular carcinoma identified by a weighted gene correlation network analysis.
Si T; Ning X; Chen H; Hu Z; Dun L; Zheng N; Huang P; Yang L; Yi P
J Gastrointest Oncol; 2021 Dec; 12(6):3079-3092. PubMed ID: 35070431
[TBL] [Abstract][Full Text] [Related]
22. Identification of potential key genes and pathways in hepatitis B virus-associated hepatocellular carcinoma by bioinformatics analyses.
Zhang X; Wang L; Yan Y
Oncol Lett; 2020 May; 19(5):3477-3486. PubMed ID: 32269621
[TBL] [Abstract][Full Text] [Related]
23. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
24. Construction and validation of prognostic signature for hepatocellular carcinoma basing on hepatitis B virus related specific genes.
Wang L; Qiu M; Wu L; Li Z; Meng X; He L; Yang B
Infect Agent Cancer; 2022 Dec; 17(1):60. PubMed ID: 36474267
[TBL] [Abstract][Full Text] [Related]
25. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
[No Abstract] [Full Text] [Related]
26. Screening of potential biomarkers in hepatitis C virus-induced hepatocellular carcinoma using bioinformatic analysis.
Liu J; Ma Z; Liu Y; Wu L; Hou Z; Li W
Oncol Lett; 2019 Sep; 18(3):2500-2508. PubMed ID: 31452738
[TBL] [Abstract][Full Text] [Related]
27. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
28. Identifying hub genes and dysregulated pathways in hepatocellular carcinoma.
Jin B; Wang W; Du G; Huang GZ; Han LT; Tang ZY; Fan DG; Li J; Zhang SZ
Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):592-601. PubMed ID: 25753876
[TBL] [Abstract][Full Text] [Related]
29. Identification of diagnostic and prognostic biomarkers, and candidate targeted agents for hepatitis B virus-associated early stage hepatocellular carcinoma based on RNA-sequencing data.
Zeng Z; Cao Z; Tang Y
Oncol Lett; 2020 Nov; 20(5):231. PubMed ID: 32968453
[TBL] [Abstract][Full Text] [Related]
30. Screening and identification of hub genes in bladder cancer by bioinformatics analysis and KIF11 is a potential prognostic biomarker.
Mo XC; Zhang ZT; Song MJ; Zhou ZQ; Zeng JX; Du YF; Sun FZ; Yang JY; He JY; Huang Y; Xia JC; Weng DS
Oncol Lett; 2021 Mar; 21(3):205. PubMed ID: 33574944
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of key genes and signal pathways of human papilloma virus-related head and neck squamous cell carcinoma].
Wang KP; Yuan YJ; Zhu JQ; Li BL; Zhang TT
Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Aug; 55(8):571-577. PubMed ID: 32842349
[No Abstract] [Full Text] [Related]
32. CCNB2, NUSAP1 and TK1 are associated with the prognosis and progression of hepatocellular carcinoma, as revealed by co-expression analysis.
Liu L; Chen A; Chen S; Song W; Yao Q; Wang P; Zhou S
Exp Ther Med; 2020 Apr; 19(4):2679-2689. PubMed ID: 32256749
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive investigation of key biomarkers and pathways in hepatitis B virus-related hepatocellular carcinoma.
Liao X; Yu T; Yang C; Huang K; Wang X; Han C; Huang R; Liu X; Yu L; Zhu G; Su H; Qin W; Deng J; Zeng X; Han B; Han Q; Liu Z; Zhou X; Liu J; Gong Y; Liu Z; Huang J; Lu L; Ye X; Peng T
J Cancer; 2019; 10(23):5689-5704. PubMed ID: 31737106
[No Abstract] [Full Text] [Related]
34. Identification of key genes and carcinogenic pathways in hepatitis B virus-associated hepatocellular carcinoma through bioinformatics analysis.
Kim SH; Hwang S; Song GW; Jung DH; Moon DB; Yang JD; Yu HC
Ann Hepatobiliary Pancreat Surg; 2022 Feb; 26(1):58-68. PubMed ID: 34907098
[TBL] [Abstract][Full Text] [Related]
35. Identification of potential biomarkers for diagnosis of hepatocellular carcinoma.
Liang XH; Feng ZP; Liu FQ; Yan R; Yin LY; Shen H; Lu HL
Exp Ther Med; 2022 Jan; 23(1):51. PubMed ID: 34917180
[TBL] [Abstract][Full Text] [Related]
36. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
37. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
[TBL] [Abstract][Full Text] [Related]
38. Bioinformatics identification of crucial genes and pathways associated with hepatocellular carcinoma.
Gao X; Wang X; Zhang S
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30341252
[TBL] [Abstract][Full Text] [Related]
39. [Screening and validation of pivotal genes in hepatitis B virus-associated hepatocellular carcinoma].
Wu YJ; Liu S; Tian YQ; Fan ZJ; Zhang L; Liu SY
Zhonghua Gan Zang Bing Za Zhi; 2023 Aug; 31(8):869-876. PubMed ID: 37723070
[No Abstract] [Full Text] [Related]
40. Critical genes of hepatocellular carcinoma revealed by network and module analysis of RNA-seq data.
Yang MR; Zhang Y; Wu XX; Chen W
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4248-4256. PubMed ID: 27831650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
